5.84 USD
-0.19 (-3.15%)
5.92 USD
+0.08 (+1.37%)
TGEN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 41 industry peers in the Building Products industry. The financial health of TGEN is average, but there are quite some concerns on its profitability. While showing a medium growth rate, TGEN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year TGEN has reported negative net income.
In the past year TGEN had a positive cash flow from operations.
TGEN had negative earnings in 4 of the past 5 years.
In multiple years TGEN reported negative operating cash flow during the last 5 years.
1.2 Ratios
With a Return On Assets value of -15.31%, TGEN is not doing good in the industry: 82.93% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -46.53%, TGEN is doing worse than 87.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.31% | ||
| ROE | -46.53% | ||
| ROIC | N/A |
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
TGEN's Gross Margin of 43.64% is amongst the best of the industry. TGEN outperforms 85.37% of its industry peers.
TGEN's Gross Margin has improved in the last couple of years.
TGEN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.64% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
2. Health
2.1 Basic Checks
TGEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, TGEN has more shares outstanding
Compared to 5 years ago, TGEN has more shares outstanding
Compared to 1 year ago, TGEN has a worse debt to assets ratio.
2.2 Solvency
TGEN has an Altman-Z score of 3.51. This indicates that TGEN is financially healthy and has little risk of bankruptcy at the moment.
TGEN has a Altman-Z score (3.51) which is comparable to the rest of the industry.
TGEN has a debt to FCF ratio of 0.63. This is a very positive value and a sign of high solvency as it would only need 0.63 years to pay back of all of its debts.
TGEN has a Debt to FCF ratio of 0.63. This is amongst the best in the industry. TGEN outperforms 87.80% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that TGEN is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, TGEN is in the better half of the industry, outperforming 70.73% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 3.51 |
ROIC/WACCN/A
WACC9.66%
2.3 Liquidity
A Current Ratio of 1.32 indicates that TGEN should not have too much problems paying its short term obligations.
TGEN has a Current ratio of 1.32. This is in the lower half of the industry: TGEN underperforms 78.05% of its industry peers.
A Quick Ratio of 0.74 indicates that TGEN may have some problems paying its short term obligations.
TGEN has a Quick ratio of 0.74. This is amonst the worse of the industry: TGEN underperforms 87.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.74 |
3. Growth
3.1 Past
The earnings per share for TGEN have decreased strongly by -220.48% in the last year.
The Revenue has been growing slightly by 2.46% in the past year.
TGEN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.52% yearly.
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%27.58%
3.2 Future
TGEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.30% yearly.
TGEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.20% yearly.
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%
EPS Next 5Y38.3%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for TGEN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for TGEN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TGEN indicates a slightly more expensive valuation: TGEN is more expensive than 65.85% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 56.39 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
TGEN's earnings are expected to decrease with -38.42% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%
5. Dividend
5.1 Amount
TGEN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
5.84
-0.19 (-3.15%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)
Earnings (Next)
Inst Owners27.2%
Inst Owner Change99.55%
Ins Owners22.95%
Ins Owner Change2.45%
Market Cap174.32M
Revenue(TTM)25.00M
Net Income(TTM)-4.76M
Analysts82.86
Price Target15.3 (161.99%)
Short Float %10.04%
Short Ratio2.26
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.96%
Min Revenue beat(2)-33.4%
Max Revenue beat(2)-30.52%
Revenue beat(4)0
Avg Revenue beat(4)-30.88%
Min Revenue beat(4)-39.65%
Max Revenue beat(4)-19.94%
Revenue beat(8)2
Avg Revenue beat(8)-17.83%
Revenue beat(12)3
Avg Revenue beat(12)-15.77%
Revenue beat(16)4
Avg Revenue beat(16)-15.85%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-52.94%
EPS NY rev (3m)-52.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 7.71 | ||
| P/FCF | 56.39 | ||
| P/OCF | 42.93 | ||
| P/B | 17.04 | ||
| P/tB | 32.46 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.1
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.1
FCFY1.77%
OCF(TTM)0.14
OCFY2.33%
SpS0.76
BVpS0.34
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -15.31% | ||
| ROE | -46.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 43.64% | ||
| FCFM | 13.67% |
ROA(3y)-13.51%
ROA(5y)-9.91%
ROE(3y)-30.18%
ROE(5y)-21.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.79%
GM growth 5Y3.17%
F-Score4
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 175.01% | ||
| Cap/Sales | 4.28% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.32 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 3.51 |
F-Score4
WACC9.66%
ROIC/WACCN/A
Cap/Depr(3y)87.45%
Cap/Depr(5y)67.63%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-53%
EPS Next 2Y-23.69%
EPS Next 3Y-38.42%
EPS Next 5Y38.3%
Revenue 1Y (TTM)2.46%
Revenue growth 3Y-9.23%
Revenue growth 5Y-5.52%
Sales Q2Q%27.58%
Revenue Next Year-2.95%
Revenue Next 2Y8.41%
Revenue Next 3Y1.41%
Revenue Next 5Y22.2%
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.59%
EBIT Next 3Y70.17%
EBIT Next 5YN/A
FCF growth 1Y457.51%
FCF growth 3Y112.98%
FCF growth 5YN/A
OCF growth 1Y596.53%
OCF growth 3Y105.19%
OCF growth 5YN/A
TECOGEN INC/WALTHAM MA / TGEN FAQ
What is the fundamental rating for TGEN stock?
ChartMill assigns a fundamental rating of 3 / 10 to TGEN.
Can you provide the valuation status for TECOGEN INC/WALTHAM MA?
ChartMill assigns a valuation rating of 0 / 10 to TECOGEN INC/WALTHAM MA (TGEN). This can be considered as Overvalued.
What is the profitability of TGEN stock?
TECOGEN INC/WALTHAM MA (TGEN) has a profitability rating of 2 / 10.
How financially healthy is TECOGEN INC/WALTHAM MA?
The financial health rating of TECOGEN INC/WALTHAM MA (TGEN) is 5 / 10.
Can you provide the expected EPS growth for TGEN stock?
The Earnings per Share (EPS) of TECOGEN INC/WALTHAM MA (TGEN) is expected to decline by -53% in the next year.